NCT04708054 2026-02-19Venetoclax to Improve Outcomes of Fractionated Busulfan Regimen in Patients With High-Risk AML and MDSM.D. Anderson Cancer CenterPhase 2/3 Recruiting324 enrolled
NCT00003816 2021-08-13Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic CancerRoswell Park Cancer InstitutePhase 2/3 Completed361 enrolled 16 charts
NCT00454480 2013-08-26Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesNational Cancer Institute (NCI)Phase 2/3 Completed2,000 enrolled